SI2694049T1 - Tapentadol za preprečevanje razvoja kronične bolečine - Google Patents

Tapentadol za preprečevanje razvoja kronične bolečine

Info

Publication number
SI2694049T1
SI2694049T1 SI201231476T SI201231476T SI2694049T1 SI 2694049 T1 SI2694049 T1 SI 2694049T1 SI 201231476 T SI201231476 T SI 201231476T SI 201231476 T SI201231476 T SI 201231476T SI 2694049 T1 SI2694049 T1 SI 2694049T1
Authority
SI
Slovenia
Prior art keywords
chronification
tapentadol
pain
preventing
preventing chronification
Prior art date
Application number
SI201231476T
Other languages
English (en)
Inventor
Klaus Schiene
Ilona Steigerwald
Michel Hamon
Johannes Schneider
Silvia Reinartz
Ulrich Jahnel
Thomas Tzschentke
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46025592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2694049(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of SI2694049T1 publication Critical patent/SI2694049T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201231476T 2011-04-05 2012-04-03 Tapentadol za preprečevanje razvoja kronične bolečine SI2694049T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11002811 2011-04-05
EP11003508 2011-04-29
PCT/EP2012/001472 WO2012136349A1 (en) 2011-04-05 2012-04-03 Tapentadol for preventing chronification of pain
EP12718064.4A EP2694049B1 (en) 2011-04-05 2012-04-03 Tapentadol for preventing chronification of pain

Publications (1)

Publication Number Publication Date
SI2694049T1 true SI2694049T1 (sl) 2019-01-31

Family

ID=46025592

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231476T SI2694049T1 (sl) 2011-04-05 2012-04-03 Tapentadol za preprečevanje razvoja kronične bolečine

Country Status (13)

Country Link
US (3) US20120309841A1 (sl)
EP (2) EP2694049B1 (sl)
JP (3) JP2014510759A (sl)
CY (1) CY1121012T1 (sl)
DK (1) DK2694049T3 (sl)
ES (1) ES2703282T3 (sl)
HR (1) HRP20181998T1 (sl)
LT (1) LT2694049T (sl)
PL (1) PL2694049T3 (sl)
PT (1) PT2694049T (sl)
RS (1) RS58064B1 (sl)
SI (1) SI2694049T1 (sl)
WO (1) WO2012136349A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2694049T (lt) 2011-04-05 2018-12-27 GrĆ¼nenthal GmbH Tapentadolis, skirtas skausmo perėjimo į lėtinį prevencijai
EP3272343B1 (en) 2011-04-29 2020-02-12 Grünenthal GmbH Tapentadol for preventing and treating depression and anxiety
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
AU2021201351B1 (en) * 2020-11-10 2022-04-21 Grünenthal GmbH Dosage form providing prolonged release of a salt of Tapentadol with L-(+)-tartaric acid

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
EP1928484B1 (en) 2005-08-26 2010-02-24 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administration of oxytocin
WO2007088473A2 (en) 2006-02-03 2007-08-09 Neurocure Ltd Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
CN101426485B (zh) * 2006-04-28 2013-02-13 格吕伦塔尔有限公司 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚和nsaid的药物组合物
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
KR101784777B1 (ko) * 2007-11-23 2017-11-06 그뤼넨탈 게엠베하 타펜타돌 조성물
US20100297181A1 (en) 2007-12-26 2010-11-25 Eisai R&D Management Co., Ltd. AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
WO2010100477A2 (en) 2009-03-03 2010-09-10 Shire Llc Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
MY174008A (en) 2009-04-30 2020-03-03 Gruenenthal Chemie Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
FR2970261B1 (fr) 2011-01-10 2013-05-03 IFP Energies Nouvelles Procede d'hydrotraitement de charges lourdes d'hydrocarbures avec des reacteurs permutables incluant au moins une etape de permutation progressive
LT2694049T (lt) * 2011-04-05 2018-12-27 GrĆ¼nenthal GmbH Tapentadolis, skirtas skausmo perėjimo į lėtinį prevencijai

Also Published As

Publication number Publication date
HRP20181998T1 (hr) 2019-01-25
PL2694049T3 (pl) 2019-07-31
JP2018048122A (ja) 2018-03-29
PT2694049T (pt) 2019-02-06
WO2012136349A1 (en) 2012-10-11
JP2014510759A (ja) 2014-05-01
LT2694049T (lt) 2018-12-27
JP6840057B2 (ja) 2021-03-10
ES2703282T3 (es) 2019-03-07
EP2694049B1 (en) 2018-10-31
US20120309841A1 (en) 2012-12-06
EP3449917A3 (en) 2019-06-05
US10813891B2 (en) 2020-10-27
EP2694049A1 (en) 2014-02-12
RS58064B1 (sr) 2019-02-28
DK2694049T3 (da) 2019-01-02
US20160354324A1 (en) 2016-12-08
CY1121012T1 (el) 2019-12-11
EP3449917A2 (en) 2019-03-06
JP2019142932A (ja) 2019-08-29
US20200009083A1 (en) 2020-01-09
US10398657B2 (en) 2019-09-03

Similar Documents

Publication Publication Date Title
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2673286A4 (en) THERAPEUTIC COMPOUNDS
EP2739221A4 (en) SURGICAL ANCHOR
EP2717855A4 (en) PROCESSING METHODS
EP2740420A4 (en) THERAPEUTIC TOOL
EP2671565A4 (en) EXTERNAL PREPARATION FOR THE SKIN
IL230433A0 (en) Pain management methods
HRP20181998T1 (hr) Tapentadol za sprječavanje kronifikacije boli
ZA201502595B (en) Therapeutic methods
EP2750508A4 (en) COMPOUNDS AND THERAPEUTIC METHODS
IL232239A0 (en) Medical use
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
ZA201308117B (en) Avian-based treatment
GB201107467D0 (en) Novel treatment of pain
GB201104632D0 (en) Use of medicament
GB201110895D0 (en) Therapeutic use
GB201105933D0 (en) Medical applicator
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102276D0 (en) Treatment